Nutrition and Integrative Medicine for Clinicians: Volume Two

Cover
Half Title
Title Page
Copyright Page
Table of Contents
Editor
Contributors
Preface
Acknowledgments
Section I Environmental Medicine, Chronic Illness and Innovations in Standard of Care
Chapter 1 Introduction to Chronic Inflammatory Response Syndrome (CIRS)
1.1 Preface
1.2 What Is a Biotoxin?
1.3 Pertinent Negatives: An Elusive Disease Hiding in Plain Sight
1.4 Genetic Susceptibility: Human Leukocyte Antigen
1.5 Visual Contrast Sensitivity
1.6 The Biotoxin Pathway in Action
1.7 Regulatory Neuropeptides: Changes in Brain Function
1.7.1 MSH – Melanocyte Stimulating Hormone
1.7.2 Additional Innate Immune Markers
1.7.3 MMP-9
1.7.4 TGFβ-1 – Transforming Growth Factor β-1
1.7.5 C4a
1.7.6 VEGF
1.7.7 ACTH/Cortisol
1.7.8 ACLA IgA/IgG/IgM
1.7.9 Anti-Gliadin Antibodies (AGA)
1.7.10 ADH/Osmolality
1.7.11 Leptin
1.8 Secondary Source of Brain Inflammation: MARCoNS
1.9 The New Language of Genes: Transcriptomics
1.10 The Future of CIRS
1.10.1 Science
1.10.2 Professionals
1.10.3 Policy
1.10.4 Final Thoughts
Bibliography
Chapter 2 The Evolution of Chronic Inflammatory Response Syndrome (CIRS) and the Biotoxin Pathway
2.1 History of CIRS
2.2 Evolution of Case Definition of CIRS
2.3 Evolution of the Paradigm of CIRS
2.4 Office Visit
2.5 Specific Symptoms
2.6 Environmental History
2.7 Post-Lyme Syndrome (CIRS-PLS)
2.8 Differential Diagnosis
2.9 Physical Exam
2.10 Ancillaries – VCS
2.11 Ancillaries – Pulmonary Artery Pressure
2.12 Ancillaries – VO2 Max and Anaerobic Threshold
2.13 Ancillaries – von Willebrand’s Factors
2.14 Ancillaries – NeuroQuant®
2.15 Biotoxin Pathway
2.16 Summary
References
Chapter 3 The Shoemaker Protocol
3.1 The Shoemaker Protocol
3.2 Step 1: Removal from Exposure
3.3 Step 2: Cholestyramine and Welchol
3.4 Step 3: Eliminate MARCoNS
3.5 Step 4: Correct Anti-Gliadin Antibodies
3.6 Step 5: Correct Androgens
3.7 Step 6: Correct ADH/Osmolality
3.8 Step 7: Correct Elevated MMP-9
3.9 Step 8: Correct VEGF
3.10 Step 9 Correct High C3a
3.11 Step 10: Correct High C4a
3.12 Step 11: Reduce High TGFβ-1
3.13 Step 12: Replace Low VIP
3.14 Graded Exercise
3.15 Re-exposure Trials
Bibliography
Chapter 4 Pediatric Chronic Inflammatory Response Syndrome
4.1 Introduction
4.2 History
4.3 Diagnostic Criteria
4.4 Pathophysiology
4.5 Cytokine Storms and CIRS Overlaps
4.6 Differences between CIRS in Adults and Children
4.7 Prevalence
4.8 Doubles
4.9 CIRS In Utero
4.10 Autism and Severe Cognitive Deficits
4.11 Headaches
4.12 Functional Abdominal Pains
4.13 Conclusions: The Future
References
Chapter 5 Mechanisms of Potential Central Nervous System Injury in Chronic Inflammatory Response Syndrome
5.1 Introduction
5.1.1 Immune Privilege of the Brain
5.2 Physical Findings
5.2.1 CIRS and the Cranial Nerves
5.2.2 Seizures, Tics, Tremors and Fasciculations
5.2.3 Unique Neurological Manifestations of Ciguatera
5.2.4 NeuroQuant® Findings in CIRS
5.3 Hypothalamic Issues
5.3.1 Headaches
5.3.2 ADH Dysregulation
5.3.3 POTS, Pre-Syncope and the Dangers of Steroid Use in CIRS Patients as It Relates to the HPA Axis
5.3.4 Vertigo
5.3.5 Leptin Dysregulation and Weight Gain
5.3.6 Androgen Dysregulation
5.3.7 The Importance of VIP and the Role of VIP Intranasal Spray
5.4 Implications for Pain
5.5 Pediatric Issues
5.5.1 Learning Disability and ADHD
5.5.2 PANS/PANDAS and OCD
5.6 Mental Health Considerations
5.6.1 Autoimmune Disease and Mental Health
5.6.2 Sleep Disturbances
5.6.3 Mood
5.6.4 Anxiety
5.6.5 Suicide
5.7 Neurodegenerative Illnesses
5.7.1 Cyanobacteria and BMAA
5.7.2 ALS and MMP-9
5.7.3 Parkinson’s Disease and the Role of Thrombin
5.7.4 Gadolinium and Parkinson’s Disease
5.7.5 Multiple Sclerosis, Thrombin and Hypercoagulability
5.7.6 Case Study of MS and CIRS from Dr. Shoemaker
5.8 Cognition and Alzheimer’s Disease
5.8.1 Executive Function Difficulties in CIRS Patients
5.8.2 Cognition, Hypoperfusion and the Blood–Brain Barrier
5.8.3 Dr. Heyman’s Neurodegenerative Model of Hypercortisolism
5.8.4 Bredesen Classification
5.8.5 Dr. Strickland’s Vascular Theory of Dementia
5.9 Summary
References
Chapter 6 Chronic Inflammatory Response Syndrome (CIRS) and Metabolism: Proliferative Physiology and Insulin Resistance
6.1 Review
6.2 Severe Exercise Intolerance Disease (SEID), Chronic Inflammatory Response Syndrome (CIRS) and Metabolism
6.3 Molecular Hypometabolism
6.4 Metabolic Acidosis
6.4.1 Specifics of Glycolysis and Pyruvate
6.4.2 Voltage-Dependent Anion Channels (VDAC) and Pyruvate
6.5 Focus on the Warburg Effect
6.6 Transcriptomics and Metabolism
6.7 Insulin Receptor Substrate 2 (IRS2)
6.8 Metabolic Complications: Pulmonary Hypertension (PAH)
6.8.1 Gamma Interferon Activated Inhibitor of Translation Complex (GAIT) Is One of Many Biologic Controls on Inflammation
6.8.2 Myeloid Cells
6.8.3 Hexosamine Biosynthetic Pathway (HBP)
6.8.3.1 Inside Insulin Resistance
6.8.4 T-Regulatory Cells and Proliferative Physiology
6.8.5 Brain Atrophy
6.9 The Study
6.9.1 Methods
6.9.2 Sequencing
6.9.3 Sequencing Analysis
6.9.4 NanoString
6.9.5 Results
6.9.6 Discussion
6.10 Conclusions
Bibliography
Chapter 7 Urinary Mycotoxin Testing: An Understanding of Its Use in the Evaluation of Human Health
7.1 Introduction
7.2 Dietary Mycotoxins
7.3 CIRS Is Not an Allergy
7.4 Faulty Geffcken Defenses
7.5 Mycotoxins in Food Production
7.6 Farm-based Prevention
7.7 Dietary Protection Factors
7.8 Mycotoxin Analysis
7.9 Mycotoxin Testing from the Literature
7.10 Urinary Mycotoxins in Human Health
7.10.1 Control Studies
7.11 The Urinary Mycotoxin Hypothesis and Junk Science
References
Chapter 8 Euthyroid Sick Syndrome, CIRS and Glyphosate Toxicity
8.1 Introduction
8.2 Much of the Action Is in the Liver
8.3 Glyphosate and Fungi
8.4 Mycotoxins, Glyphosate and Mitochondria
8.5 An Essential Role for Neutrophils
8.6 Interleukin-6 Drives Inflammation
8.7 Granule Release by Neutrophils
8.8 Clathrin-Coated Pits and DIO3
8.9 Heparan Sulfate and Fibrosis
8.10 Putting It All Together
8.11 Therapies for NTIS
8.12 Chapter Summary
References
Chapter 9 Are Water-Damaged Buildings Safe? The Literature Speaks
9.1 Introduction
9.2 Early Literature
9.3 Naysayer Literature before 2011
9.4 Summary Literature before 2011
9.5 Yaysayer Literature before 2011
9.6 Literature from 2011 to the Present
9.7 Conclusions
References
Chapter 10 Guidelines for Public Policy Considerations in Building Standards: Safe Buildings Are a Human Right
10.1 What Is a Water-Damaged Building?
10.2 Water Activity
10.3 How Does Water Get Inside? The Value of Vigilant Maintenance of the Building Envelope
10.3.1 Roofs
10.3.2 Windows
10.3.3 Doors
10.3.4 Gutters
10.3.5 Siding (Cladding)
10.3.6 Vinyl Siding
10.3.7 Crawl Spaces
10.3.8 Internal Sources
10.3.9 Cooking
10.3.10 Human Sources
10.3.11 Decks
10.3.12 Stilts
10.4 Sequential Activation of Innate Immune Effects (SAIIE): Defining Causation
10.5 Perspective on the Treatment of WDB
10.6 Transcriptomics
10.7 For the Future
10.8 Summary
Bibliography
Chapter 11 Building Science and Human Health
11.1 What Is a Water-Damaged Building?
11.2 Physical Properties of Water
11.3 Remediation
11.4 Considerations Regarding the Indoor Environmental Investigation
11.5 The Water-Damage Building Investigation
11.5.1 Roofing
11.5.1.1 Flat Roofs
11.5.1.2 Steep Roofs
11.5.2 Attic Ventilation
11.5.3 Exterior Drainage
11.5.4 Interior Drainage
11.5.5 Crawl spaces
11.5.6 Exterior
11.5.7 Plumbing
11.5.8 Heating, Ventilation and Air Conditioning (HVAC)
11.5.9 Topography
11.6 Methods of Investigation
11.7 Corrections and Solutions
Bibliography
Chapter 12 Legal and Ethical Considerations in Mold, Mycotoxins, CIRS and Building Biology
12.1 Introduction
12.2 History
12.3 Truth versus Justice
12.4 History of Mold in the Courtroom
12.5 Mold in the Courtroom Today
12.6 Mold in the Courtroom Today: Expert Witnesses
12.7 Mold in the Courtroom Today: ACOEM 2002
12.8 Mold in the Courtroom Today: Deposition and Courtroom Tactics
12.9 Where Is the CDC in All of This?
12.10 Conclusions
References
Chapter 13 Dying for Representation: My Own Story: Founding Just Well
13.1 Kristina 2.0
13.2 Dying for Representation
13.2.1 Elements of a Viable Mold Case
13.2.2 Understanding the Causation Standard and the Medical Literature
13.2.3 Juries Care
13.2.3 Conclusion: A United Front
Appendix: Additional Verdicts
References
Chapter 14 The Intersection between Soil, Nutrients, Toxins and Human Health
References
Chapter 15 Current Clinical and Research Considerations for ME/CFS
15.1 Introduction
15.2 Nutritional and Environmental Aspects in the Evaluation and Treatment of ME/CFS
15.2.1 Risk Factors for Nutritional Deficiencies in Patients with ME/CFS
15.2.2 Environmental Exposure
15.2.3 Genetic Predisposition
15.2.4 Nutritional Evaluation of Patients with ME/CFS
15.2.5 Nutritional Deficiencies Found in Patients with ME/CFS
15.2.6 Nutritional Therapeutic Approach
15.3 Autoimmunity
15.4 Dysautonomia
15.4.1 Antibodies against the Autonomic Nervous System
15.4.2 Small Fiber Neuropathy (SFN)
15.4.3 Craniocervical Instability (CCI) and Mast Cell Activation
15.4.4 Reduced Cerebral Blood Flow
15.5 Infections
15.6 Sleep/Pain/Neuroinflammation
15.7 Hormones
15.8 Integrative Treatment Modalities
15.9 Conclusion
References
Chapter 16 Allostatic Load/Overload and Myalgic Encephalitis/Chronic Fatigue Syndrome (ME/CFS)
16.1 Introduction
16.1.1 Lack of Consensus on Virtually All Aspects of ME/CFS
16.1.2 Basic Epidemiologic Data
16.1.3 Typical Patient Presentation
16.2 Currently Accepted Guidelines for Diagnosis
16.3 Traditional Approaches to Assessment and Treatment of ME/CFS
16.4 Why a New Model of Assessment and Patient Management Is Needed
16.5 The Reality of the ME/CFS Patient Experience
16.6 How Efficacious Have Pharmaceutical Therapies Been with ME/CFS?
16.7 Research Supporting the Hypothesis That ME/CFS Has Many Possible Pathophysiologic Mechanisms That Vary from Patient to Patient
16.7.1 Overview
16.7.2 Dysregulated Amino Acid Metabolism and Krebs Cycle Substrates
16.7.3 Dysregulated Krebs Cycle Function
16.7.4 Dysregulation of Inflammatory Mediators
16.7.5 Dysregulation of Gut Microflora
16.7.6 Interactions of All of the Above
16.7.7 An In-Depth Examination of the Key Metabolic Imbalances Often Encountered in ME/CFS Patients
16.8 Additional Research on the Pathophysiology of ME/CFS
16.8.1 Dysregulation of Inflammatory Mediators
16.8.2 Oxidative/Nitrosative Stress Induced by Inflammation
16.8.3 Neurotransmitter Disturbances
16.8.4 Neuroendocrine Imbalances
16.8.5 Suboptimal Mitochondrial Function and Energy Production
16.8.6 GI Microbiome Imbalances, Increased Intestinal Permeability, and Bacterial Translocation
16.8.7 Cardiovascular Disturbances
16.8.8 Thyroid Dysfunction
16.8.9 Genetic Polymorphisms
16.9 Allostatic Overload – A More Accurate Model That Reflects the True Nature of ME/CFS
16.9.1 Allostasis and Allostatic Overload – a Definition
16.9.2 Allostatic Load and ME/CFS
16.10 Key Environmental Stressors That Lead to Allostatic Load in ME/CFS Patients
16.10.1 Infectious Disease
16.10.2 Chemical and Metal Toxins
16.10.3 Disturbances in Gut Microflora
16.11 Putting It All Together: A Patient-Specific Approach That Addresses Both the Environmental Stressors That Increase Allostatic Load and the Specific Metabolic Imbalances That Comprise Allostatic Load
16.12 Environmental Stressors That Create Allostatic Load in ME/CFS Patients
16.12.1 Nutrient Deficiency
16.12.2 Psychological Stress
16.12.3 Environmental Pollutants
16.12.4 Disturbances of Gut Microflora
16.12.5 Chronic Infection
16.13 Key Metabolic Responses to Environmental Stressors That Comprise Allostatic Load in ME/CFS Patients
16.13.1 Inflammation
16.13.2 Mitochondrial Dysfunction
16.14 Some Final Thoughts
References
Section II Functional and Integrative Medicine: Perspectives in Deep Healing
Chapter 17 Soil Health Impacts on Water and Nutrient Use Efficiency
17.1 Introduction
17.2 Soil Health
17.3 Resource Use Efficiency
17.3.1 Water Use Efficiency
17.3.2 Nutrient Use Efficiency
17.4 Relationship of Soil Health with Resource Use Efficiency
17.5 Linkage of Soil Health, WUE, and NUE to Nutrition
17.6 Challenges
References
Chapter 18 Mitochondrial Correction as a Cancer Therapy
18.1 Introduction
18.2 Mitochondria and Cancer
18.3 Mitochondrial Correction
18.4 Diet
18.5 Dietary Supplementation: Descriptions and Suggestions for Adult Dosages
18.5.1 CoQ10 (Ubiquinone)
18.5.2 L-Carnitine (3-Hydroxy-4-Ν-Trimethylaminobutyrate)
18.5.3 Acetyl-L-Carnitine
18.5.4 Idebenone (2,3-​Dimet​hoxy-​5-Met​hyl-6​-(10-​Hydro​xydec​yl)-1​,4-Be​nzoqu​inone​)
18.5.5 N-Acetyl Cysteine
18.5.6 (R) Alpha-Lipoic Acid (1,2-Dithiolane-3-Pentanoic Acid)
18.5.7 Omega 3 Fatty Acids (Eicosapentaenoic acid [EPA] and Docosahexaenoic acid [DHA])
18.5.8 Vitamin C (Ascorbic Acid)
18.5.9 B-Complex Vitamins
18.5.9.1 Thiamine (Vitamin B1)
18.5.9.2 Riboflavin (Vitamin B2)
18.5.9.3 Niacin (Vitamin B3)
18.5.9.4 Pantothenic acid (Vitamin B5)
18.5.9.5 Magnesium
18.5.9.6 Phospholipids
18.5.9.7 Ginkgo biloba (Salisburia adiantifolia)
18.5.9.8 Succinate (Succinic Acid)
18.5.9.9 Pyrroloquinoline Quinone (PQQ)
18.5.9.10 Sodium Bicarbonate
18.5.9.11 Nicotinamide Adenine Dinucleotide (NADH)
18.5.9.12 D-Ribose
18.5.9.13 Citrate
18.5.9.14 Creatine
18.5.9.15 Shilajit
18.5.9.16 Mushrooms
18.5.9.17 Herbs
18.5.9.18 Melatonin
18.5.9.19 Arginine
18.5.9.20 Resveratrol
18.5.9.21 Quercetin
18.5.9.22 Glutathione
18.5.9.23 Dichloroacetate (DCA)
18.5.9.24 3-Bromopyruvate
18.5.9.25 2-Deoxyglucose
18.5.9.26 EPI-743
18.6 Lifestyle and Mitochondria
18.6.1 Exercise
18.7 Hyperbaric (High Pressure, 100%) Oxygen Therapy (HBOT)
18.8 Intravenous Laser Therapy (IVLT)
18.9 Conclusions
References
Chapter 19 The Impact of Untreated Sleep Disorders on Children’s Cognition, Academics, Behaviors, Health and Safety – Screening, Identification and Treatment
19.1 Introduction
19.2 Major Pediatric Sleep Disorders, Prevalence Rates, Negative Impact on Daytime Functioning and Health, and Possible Treatments or Interventions
19.3 Sleep-Related Breathing Disorders (SRBDs)
19.3.1 Prevalence Rate of SRBDs
19.3.2 Negative Impact of OSA on Daytime Functioning and Health
19.3.3 Possible Treatment Interventions for SRBDs/OSA
19.4 Periodic Limb Movement Disorder (PLMD) and Restless Legs Syndrome (RLS)
19.4.1 Prevalence Rates of PLMD and RLS
19.4.2 Negative Impact of PLMD and RLS on Daytime Functioning and Health
19.4.3 Treatment Options for PLMD and RLS
19.5 Narcolepsy
19.5.1 Prevalence Rate of Narcolepsy
19.5.2 Negative Impact of Narcolepsy on Daytime Functioning, Health and Quality of Life
19.5.3 Treatment of Narcolepsy
19.6 Delayed Sleep Phase Syndrome (DSPS) and Behavioral Insomnia of Childhood (BIC)
19.6.1 Prevalence Rate of DSPS
19.6.2 Negative Impact of DSPS on Daytime Functioning and Health
19.6.3 Treatment or Interventions for DSPS and BIC
19.7 Miscellaneous Consequences of Any of the Above-Mentioned Sleep Disorders
19.8 Sleep Screening for Children and Youth
19.9 Conclusions
References
Appendix 1
Appendix 2
Chapter 20 Circadian and Mitochondrial Effects of Light
20.1 Introduction
20.2 Circadian Biology
20.3 Melatonin
20.4 Cortisol
20.5 Circadian Oscillators
20.6 Zeitgebers and Melanopsin
20.7 Biophysical Evolution
20.7.1 Mitochondrial Connection
20.8 DHA
20.9 Blue Light
20.10 Technology and Screens
20.11 Light at Night
20.12 Blocking the Blues
20.13 Conclusion
References
Chapter 21 COVID-19: Pathogenesis and Nutritional Support for Prophylaxis and Symptom De-Escalation
21.1 Introduction
21.2 Proximal Origin of Virus
21.3 Mode of Virus Entry into Human Cells
21.4 Organ Distribution of ACE2
21.5 COVID-19 Stages, Symptoms, Treatment Approach and Disease Classification
21.6 The “Cytokine Storm” (Hyper-Inflammation) and Cytokine Profiles in Moderate and Severe COVID-19
21.7 Nutrient Transfer, Gut Microbiome and Immunity
21.7.1 Gut Microbiome and GALT
21.7.2 Gut Mechanisms Preventing Infection
21.7.3 Innate and Adaptive Immune Systems of the GALT
21.7.4 The Gut–Lung Axis in Respiratory Infection
21.7.5 Gut-Derived SCFAs and Respiratory Virus Model
21.7.6 Gut Microbiome Modification for Prophylaxis and Treatment of COVID-19
21.8 Food Group Components and the Inflammatory Trigger Setting
21.8.1 The Carbohydrate–Protein–Fat Balance and Inflammation
21.8.2 Dietary Polyunsaturated Fatty Acids and Control of Inflammation
21.9 Antioxidant and Metabolic Support for COVID-19
21.9.1 Cellular Oxidative Stress and Infection
21.9.2 Vitamin C (Ascorbic Acid) and Symptom De-escalation
21.9.3 Vitamin E and COVID-19
21.9.4 Ascorbic Acid, L-Lysine and the “Bradykinin Storm”
21.9.5 N-Acetylcysteine (NAC) Support for Glutathione Synthesis and Recycling
21.10 Melatonin
21.11 B Vitamins and COVID-19
21.12 Minerals and Metabolic Support
21.13 Vitamin D and COVID-19
21.13.1 Antimicrobial Effects of Vitamin D Binding to the VDR
21.13.2 Anti-Inflammatory and Inflammatory Effects of Vitamin D
21.13.3 Vitamin D Deficiency, SARS-CoV-2 Infection and COVID-19 Severity
21.14 Phytonutrients
21.14.1 Quercetin
21.14.2 Epigallocatechin Gallate
21.14.3 Berberine and Resveratrol
21.14.4 Sweet Wormwood
21.15 Overview Discussion and Consensus Nutritional Recommendations (Consensus-COVID)
References
Chapter 22 A Psychotherapeutic Approach to Living Life Forward: The Neuroplastic Synergy of Mindfulness and Intentionality
22.1 Introduction: A Synergistic Approach to Mental Health
22.1.1 Old Bad and New Good Psychic Structures
22.1.2 A Quantum-Neuroscientific Approach to Healing
22.1.3 When One Door Closes, Another Door Opens
22.1.4 The Narrative Changes but the Episodic Memory Remains
22.1.5 Maria Gains Perspective and Reframes Her Father’s Abuse
22.1.6 Alloying the Pure Gold of Analysis
22.1.7 Brief Overview of the Five Modes of Therapeutic Action
22.1.8 Understanding Life Backward but Living Life Forward
22.1.9 Memory Integration (Models 1–4) versus Memory Reconsolidation (Model 5)
22.1.10 De Novo Protein Synthesis
22.1.11 Inhibition of Memory Recall by the Beta-Blocker Propranolol
22.1.12 Optimal Stress within the Window of Tolerance
22.2 Jumpstarting Analysis Paralysis
22.2.1 Refractory Inertia and Thwarted Potential
22.2.2 Documented Effectiveness of Short-Term, Intensive Treatments
22.2.3 Immediate and Dramatic Relief of Symptoms
22.2.4 Juanita’s Mind-Boggling Experience with an Opioid
22.2.5 Alina’s Miraculous Release from the Tyranny of Obsessive Love
22.2.6 Retrograde Amnesia – Richard Rubin and His Team of Researchers
22.2.7 Interdependence of the Five Models
22.3 The Dynamic Nature of Memory: Rewiring the Brain and Reprogramming the Mind
22.3.1 Brain Imaging Techniques to Map Brain Activity
22.3.2 Violation of Expectation
22.3.3 Expansion and Contraction of Glial Cells
22.3.4 The Introduction of Something New
22.3.5 Eye Movement Desensitization and Reprocessing (EMDR) Therapy
22.3.6 Lakisha – From Powerless Victim to Empowered Survivor
22.3.7 Hebbian Theory and Associative Learning
22.3.8 The Brain’s Neuroplasticity
22.4 Model 5 Quantum Disentanglement Statements
22.4.1 The Neuroplastic Synergy of Mindfulness and Intentionality
22.4.2 Mindfulness – Compassionate Witnessing of the Present Moment
22.4.3 Intentionality – Harnessing the Pluripotent Potential of Every Moment in Time
22.4.4 A Quantum Approach to Therapeutic Change
22.4.5 From Determinism to Free Will
22.4.6 The Creation of Destabilizing and Galvanizing Internal Tension to Provoke Change
22.4.7 Mindful Awareness
22.4.8 Intentioned Action
22.4.9 Co-Constructed Model 5 Quantum Disentanglement “I” Statements
22.5 Conclusion
References
Chapter 23 Mind, Consciousness and the Design Nature of Sound
23.1 Introduction
23.2 Vibration
23.3 Cymatic Phenomenology Descriptions
23.4 Neuroanatomy/Hearing/Neural Science
23.5 Consciousness
23.6 Conclusion
References
Chapter 24 The Use of Sound and Color in Clinical Application
24.1 Introduction
24.2 Holistic Syntonic Phototherapy and Sound Healing
24.2.1 Biosonic C and G Tuning Forks
24.2.2 Biosonic Tuning Fork Recordings
24.3 Color Sense Ability and Sound
24.3.1 Green
24.3.1.1 Affirmation for Green
24.3.2 Blue
24.3.2.1 Affirmation for Blue
24.3.3 Red
24.3.3.1 Affirmation for Red
24.3.4 Orange
24.3.4.1 Affirmation for Orange
24.3.5 Yellow
24.3.5.1 Affirmation for Yellow
24.4 Therapeutic Discussion
24.5 Sound and Color Frequency and Resonance
24.6 Biosonic Color Glasses
24.6.1 How to Use Biosonic Color Glasses
24.7 Phenomenological Sensory Integration (PSI) Exercises
24.7.1 PSI Exercise 1: C and G
24.7.2 PSI Exercise 2: Specific Sound and Color Explorations
24.7.3 PSI Exercise 3: The Purpose of This Exercise Is to Build Trust in Your Sensory Integration Abilities
24.7.4 PSI Exercise #4: A Result of Working with Tuned Sound and Color Resonances Is the Ability to Develop and Trust Your Sound and Color Sensibility
24.7.5 PSI Discussion
24.7.5.1 Mauve
24.8 Overview and Conclusion
References
Bibliography
Chapter 25 The Human Body: A Biological Sound Healing Instrument
25.1 Introduction
25.2 What Is Sound?
25.2.1 Wave Propagation
25.3 Everything Is Vibration
25.3.1 Vibration Is the Universal Language
25.4 Voice
25.5 Voice Production Requires the Entire Body
25.6 Our Bodies Are Resonators for Sound
25.7 The Vocal Cords
25.7.1 Muscle Anatomy and Functions of Vocal Cords
25.7.2 Vocal Fold Structure
25.7.3 Wave Motion of the Vocal Cords
25.7.4 The Great Unknown
25.8 Speech Sound
25.8.1 Speech Learning in Infancy
25.8.2 The Power of the Word
25.8.3 Visible Speech – Aerodynamic Sound Forms
25.8.4 Coarticulation in Speech
25.8.5 The Nasal Cavity
25.8.6 Speech Is Gesture
25.9 The Vortex – a Phenomenon of Nature
25.10 The Creative Power of Speech in Ancient Artwork
25.11 The Sensory Cycle
25.11.1 The Mirror of the Soul
25.12 The Ear
25.12.1 The External Ear
25.12.2 The Middle Ear
25.12.3 The Inner Ear
25.12.4 The Vestibular System
25.13 Voice as a Healing Instrument
25.13.1 The Chakras and Auras – the Body’s Energy Template
25.13.2 Vocal Toning
25.13.3 Mantra
25.14 Alankar – My Personal Experience with Sound Healing through Voice
References
Chapter 26 Art in Medicine: Tapping into Creativity for Healing the Mind/Body
26.1 Introduction
26.2 Art and Creativity in Historical Perspective
26.2.1 Turn of the Century (Nineteenth to Twentieth)
26.2.2 Mid-Twentieth Century
26.2.3 Late Twentieth Century to the Present
26.3 New Tools for Health and Wellness
26.3.1 Four Examples of Holistic Design
26.3.2 Frame Analysis – ChoiceCompass as Example
26.3.3 Repertoire-Building Research – Inner Balance as Example
26.3.4 Research on Fundamental Methods of Inquiry and Theory – Akila AI as Example
26.3.5 Research on Process Reflection in Action – OpenBCI as Example
26.4 Conclusion
References
Chapter 27 Information Medicine for the 21st Century: Physicks and Physics
27.1 Introduction
27.2 Biology Runs on Low Entropy
27.3 Information, the Irreducible Factor in Nature
27.4 Target Experiments Showing the Power of Human Intention to Alter Material Properties
27.5 Dual Realities and Field Effects
27.6 From Bench to Real-World Application of Information Medicine
27.7 God’s Universe and Conclusions
References
Chapter 28 Birthing the Light, Making Childbirth a Positive Experience
Translation
28.1 Introduction
28.2 Historical Perspective of Childbirth
28.3 The Journey Begins: Understanding Conception and the Zinc Flash
28.4 Models of Care – Technocratic to Quantum
28.5 Hormones as Messengers – Reproductive and Birthing Hormones
28.6 Microbiome – the Key to Human Health
28.7 Highlighting the Current Perspective
28.7.1 Patient’s Point of View
28.8 Factors Influencing Birth Preferences
28.8.1 Childbirth Classes
28.8.2 Owning One’s Childbirth
28.8.3 Role of Physical and Mental Strength Building in Prospective Mothers
28.8.4 Role of Birth Companion in Labor
28.8.5 Role of Healthcare Providers
28.9 Closing the Loop or Coming Full Circle
28.9.1 The Birth Atlas: Understanding the Uterus, Cervix, and Dilation and Effacement
28.9.2 Cardinal Movements of Labor: How the Baby Navigates the Pelvis
28.9.3 The Holistic Stages of Labor: A New Language for a New Paradigm
28.10 Conclusion
Acknowledgements
References
Chapter 29 An Introduction to Hidden Societal Enigmas That Have Significant Impact on Mental, Physical and Spiritual Health
29.1 Introduction
29.2 Shamans as Humanity’s First Healers
29.3 Psychobiology of Shamanic States of Consciousness
29.4 Neoshamanism
29.5 The Shamanic versus Western Model of Mental Illness
29.6 Shamanism, Platonic and Jungian Psychology
29.7 Parallels between Shamanism and Eastern Philosophy
29.8 Nadis, Meridians and the Primovascular System:
29.9 Chakra Anatomy and the Luminous Energy Field
29.9.1 Root Chakra: Trust versus Mistrust
29.9.2 Sacral Chakra: Autonomy versus Shame
29.9.3 Solar Plexus Chakra: Initiative versus Guilt, Industry versus Inferiority, Identity versus Role Confusion
29.9.4 Heart Chakra: Intimacy versus Isolation
29.9.5 Throat Chakra: Generativity versus Stagnation
29.9.6 Third Eye Chakra: Integrity versus Despair
29.9.7 Crown Chakra: Mastery versus Distraction
29.10 The Integrative Psychology of the Future
References
Index